{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T16:00:00Z","timestamp":1770048000634,"version":"3.49.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203667"],"award-info":[{"award-number":["82203667"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-026-02002-3","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T05:17:17Z","timestamp":1770009437000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanistic insights into EOC-PMCs-Induced macrophage polarization via the Galnt15-PPAR\u03b3 pathway"],"prefix":"10.1186","author":[{"given":"Shuangge","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huachi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoduan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"2002_CR1","doi-asserted-by":"crossref","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 73(1):17\u201348.","DOI":"10.3322\/caac.21763"},{"key":"2002_CR2","doi-asserted-by":"crossref","unstructured":"Han B, Zheng R, Zeng H, Wang S, Sun K, Chen R, Li L, Wei W, He J. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent. 2024;4(1):47\u201353.","DOI":"10.1016\/j.jncc.2024.01.006"},{"issue":"Suppl 1","key":"2002_CR3","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/annonc\/mdw083","volume":"27","author":"J Krzystyniak","year":"2016","unstructured":"Krzystyniak J, Ceppi L, Dizon DS, Birrer MJ. Epithelial ovarian cancer: the molecular genetics of epithelial ovarian cancer. Ann Oncol. 2016;27(Suppl 1):i4\u201310.","journal-title":"Ann Oncol"},{"key":"2002_CR4","doi-asserted-by":"crossref","unstructured":"Chornokur G, Amankwah EK, Schildkraut JM, Phelan CM. Global ovarian cancer health disparities. Gynecol Oncol. 2013;129(1):258\u201364.","DOI":"10.1016\/j.ygyno.2012.12.016"},{"issue":"3","key":"2002_CR5","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/AOG.0b013e318264f794","volume":"120","author":"LA Baldwin","year":"2012","unstructured":"Baldwin LA, Huang B, Miller RW, Tucker T, Goodrich ST, Podzielinski I, DeSimone CP, Ueland FR, van Nagell JR. Seamon. Ten-year relative survival for epithelial ovarian cancer. Obstet Gynecol. 2012;120(3):612\u20138.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2002_CR6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/jnci\/djy071","volume":"111","author":"LC Peres","year":"2019","unstructured":"Peres LC, Cushing-Haugen KL, K\u00f6bel M, Harris HR, Berchuck A, Rossing MA, Schildkraut JM. Doherty. Invasive epithelial ovarian cancer survival by histotype and disease stage. J Natl Cancer Inst. 2019;111(1):60\u20138.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"2002_CR7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41416-020-0875-x","volume":"123","author":"CE Ford","year":"2020","unstructured":"Ford CE, Werner B, Hacker NF, Warton K. The untapped potential of Ascites in ovarian cancer research and treatment. Br J Cancer. 2020;123(1):9\u201316.","journal-title":"Br J Cancer"},{"issue":"4","key":"2002_CR8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrc3432","volume":"13","author":"E Kipps","year":"2013","unstructured":"Kipps E, Tan DS, Kaye SB. Meeting the challenge of Ascites in ovarian cancer: new avenues for therapy and research. Nat Rev Cancer. 2013;13(4):273\u201382.","journal-title":"Nat Rev Cancer"},{"key":"2002_CR9","doi-asserted-by":"crossref","unstructured":"Zheng X, Xinjing W, Xi C, Zhaoyuan L, Yujia Y, Xiaoduan L, Zhihao H, Ziliang W, Wei G, Florent G, Ziyi L, Zemin Z, Xipeng W. Single-cell analyses implicate Ascites in remodeling the ecosystems of primary and metastatic tumors in ovarian cancer. Nat Cancer. 2023;4(8):1138\u201356.","DOI":"10.1038\/s43018-023-00599-8"},{"key":"2002_CR10","doi-asserted-by":"crossref","unstructured":"Esther Schoutrop M-G, Lidia L, Stephanie M, Jonas L, Kaisa D, Hanna. Magalhaes Isabelle. Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment. Sem Cancer Biol. 2022;86(Pt 3):207\u201323.","DOI":"10.1016\/j.semcancer.2022.03.027"},{"key":"2002_CR11","doi-asserted-by":"crossref","unstructured":"Almeida-Nunes DL, Mendes-Frias A, Silvestre R, Dinis-Oliveira RJ. S. Ricardo. Immune tumor microenvironment in ovarian cancer Ascites. Int J Mol Sci. 2022;23(18):10692.","DOI":"10.3390\/ijms231810692"},{"key":"2002_CR12","doi-asserted-by":"crossref","unstructured":"Paku\u0142a M, Miku\u0142a-Pietrasik J, Witucka A, Kostka-Jeziorny K, Uruski P, Moszy\u0144ski R, Naumowicz E, Sajdak S, Tykarski A. K. Ksi\u0105\u017cek. The Epithelial-Mesenchymal transition initiated by malignant Ascites underlies the transmesothelial invasion of ovarian cancer cells. Int J Mol Sci. 2019;20(1):137.","DOI":"10.3390\/ijms20010137"},{"key":"2002_CR13","first-page":"53","volume":"7","author":"A Ponton-Almodovar","year":"2024","unstructured":"Ponton-Almodovar A, Sanderson S, Rattan R, Bernard JJ. Horibata. Ovarian tumor microenvironment contributes to tumor progression and chemoresistance. Cancer Drug Resist. 2024;7:53.","journal-title":"Cancer Drug Resist"},{"key":"2002_CR14","doi-asserted-by":"crossref","first-page":"985187","DOI":"10.3389\/fimmu.2022.985187","volume":"13","author":"Y Ren","year":"2022","unstructured":"Ren Y, Li R, Feng H, Xie J, Gao L, Chu S, Li Y, Meng F, Ning Y. Single-cell sequencing reveals effects of chemotherapy on the immune landscape and TCR\/BCR clonal expansion in a relapsed ovarian cancer patient. Front Immunol. 2022;13:985187.","journal-title":"Front Immunol"},{"issue":"1","key":"2002_CR15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","volume":"30","author":"I Vitale","year":"2019","unstructured":"Vitale I, Manic G, Coussens LM, Kroemer G. Galluzzi. Macrophages and metabolism in the tumor microenvironment. Cell Metab. 2019;30(1):36\u201350.","journal-title":"Cell Metab"},{"issue":"1","key":"2002_CR16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ijc.28335","volume":"134","author":"S Reinartz","year":"2014","unstructured":"Reinartz S, Schumann T, Finkernagel F, Wortmann A, Jansen JM, Meissner W, Krause M, Schw\u00f6rer AM, Wagner U, M\u00fcller-Br\u00fcsselbach S, M\u00fcller R. Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: correlation of CD163 expression, cytokine levels and early relapse. Int J Cancer. 2014;134(1):32\u201342.","journal-title":"Int J Cancer"},{"issue":"12","key":"2002_CR17","doi-asserted-by":"crossref","first-page":"e2411314","DOI":"10.1002\/advs.202411314","volume":"12","author":"H Luo","year":"2025","unstructured":"Luo H, She X, Zhang Y, Xie B, Zhang S, Li Q, Zhou Y, Guo S, Zhang S, Jiang Y, Dong Y, He J, Wang L, Zhang Q, Zhuang Y, Deng P, Wang F, Liu J, Chen X, Nie H. He. PLIN2 promotes lipid accumulation in Ascites-Associated macrophages and ovarian cancer progression by HIF1\u03b1\/SPP1 signaling. Adv Sci. 2025;12(12):e2411314.","journal-title":"Adv Sci"},{"issue":"6","key":"2002_CR18","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/s41416-022-01887-3","volume":"127","author":"K Kamat","year":"2022","unstructured":"Kamat K, Krishnan V. Dorigo. Macrophage-derived CCL23 upregulates expression of T-cell exhaustion markers in ovarian cancer. Br J Cancer. 2022;127(6):1026\u201333.","journal-title":"Br J Cancer"},{"key":"2002_CR19","doi-asserted-by":"crossref","first-page":"112876","DOI":"10.1016\/j.intimp.2024.112876","volume":"141","author":"X Liu","year":"2024","unstructured":"Liu X, Wang X, Zhang J, Tian T, Ning Y, Chen Y, Li G, Cui Z. Myc-mediated Inhibition of HIF1a degradation promotes M2 macrophage polarization and impairs CD8 T cell function through lactic acid secretion in ovarian cancer. Int Immunopharmacol. 2024;141:112876.","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"2002_CR20","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1158\/2326-6066.CIR-17-0479","volume":"6","author":"J Zhou","year":"2018","unstructured":"Zhou J, Li X, Wu X, Zhang T, Zhu Q, Wang X, Wang H, Wang K, Lin Y, Wang X. Exosomes released from Tumor-Associated macrophages transfer MiRNAs that induce a Treg\/Th17 cell imbalance in epithelial ovarian cancer. Cancer Immunol Res. 2018;6(12):1578\u201392.","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"2002_CR21","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/eji.201344130","volume":"44","author":"F Bellora","year":"2014","unstructured":"Bellora F, Castriconi R, Dondero A, Pessino A, Nencioni A, Liggieri G, Moretta L, Mantovani A, Moretta A, Bottino C. TLR activation of tumor-associated macrophages from ovarian cancer patients triggers cytolytic activity of NK cells. Eur J Immunol. 2014;44(6):1814\u201322.","journal-title":"Eur J Immunol"},{"issue":"2","key":"2002_CR22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1158\/2159-8290.CD-11-0117","volume":"1","author":"HA Kenny","year":"2011","unstructured":"Kenny HA, Nieman KM, Mitra AK, Lengyel E. The first line of intra-abdominal metastatic attack: breaching the mesothelial cell layer. Cancer Discov. 2011;1(2):100\u20132.","journal-title":"Cancer Discov"},{"key":"2002_CR23","doi-asserted-by":"crossref","unstructured":"Pascual-Ant\u00f3n L, Carde\u00f1es B, Sainz R, de la Cuesta L, Gonz\u00e1lez-Cortijo M, L\u00f3pez-Cabrera C, Caba\u00f1as P. Sandoval. Mesothelial-to-Mesenchymal transition and exosomes in peritoneal metastasis of ovarian cancer. Int J Mol Sci. 2021;22(21):11496.","DOI":"10.3390\/ijms222111496"},{"issue":"1","key":"2002_CR24","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12943-019-1049-4","volume":"18","author":"W Feng","year":"2019","unstructured":"Feng W, Dean DC, Hornicek FJ, Shi H. Duan. Exosomes promote pre-metastatic niche formation in ovarian cancer. Mol Cancer. 2019;18(1):124.","journal-title":"Mol Cancer"},{"issue":"3","key":"2002_CR25","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00018-017-2663-1","volume":"75","author":"J Miku\u0142a-Pietrasik","year":"2018","unstructured":"Miku\u0142a-Pietrasik J, Uruski P, Tykarski A, Ksi\u0105\u017cek K. The peritoneal soil for a cancerous seed: a comprehensive review of the pathogenesis of intraperitoneal cancer metastases. Cell Mol Life Sci. 2018;75(3):509\u201325.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"2002_CR26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13046-021-01899-6","volume":"40","author":"C Wang","year":"2021","unstructured":"Wang C, Wang J, Shen X, Li M, Yue Y, Cheng X, Lu W, Wang X, Xie X. LncRNA SPOCD1-AS from ovarian cancer extracellular vesicles remodels mesothelial cells to promote peritoneal metastasis via interacting with G3BP1. J Experimental Clin Cancer Res. 2021;40(1):101.","journal-title":"J Experimental Clin Cancer Res"},{"key":"2002_CR27","doi-asserted-by":"crossref","unstructured":"Li X, Meiling T, Qinyi Z, Xinjing W, Yingying L. Wang Xipeng. The Exosomal integrin \u03b15\u03b21\/AEP complex derived from epithelial ovarian cancer cells promotes peritoneal metastasis through regulating mesothelial cell proliferation and migration. Cell Oncol. 2020;43(2):263\u201377.","DOI":"10.1007\/s13402-019-00486-4"},{"issue":"1","key":"2002_CR28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.immuni.2019.05.010","volume":"51","author":"MB Buechler","year":"2019","unstructured":"Buechler MB, Kim KW, Onufer EJ, Williams JW, Little CC, Dominguez CX, Li Q, Sandoval W, Cooper JE, Harris CA, Junttila MR, Randolph GJ. Turley. A stromal niche defined by expression of the transcription factor WT1 mediates programming and homeostasis of Cavity-Resident macrophages. Immunity. 2019;51(1):119\u2013e130115.","journal-title":"Immunity"},{"issue":"11","key":"2002_CR29","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/eji.201948164","volume":"49","author":"S Ivanov","year":"2019","unstructured":"Ivanov S, Gallerand A, Gros M, Stunault MI, Merlin J, Vaillant N, Yvan-Charvet L. Guinamard. Mesothelial cell CSF1 sustains peritoneal macrophage proliferation. Eur J Immunol. 2019;49(11):2012\u20138.","journal-title":"Eur J Immunol"},{"issue":"6","key":"2002_CR30","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.kint.2018.12.030","volume":"95","author":"A Helmke","year":"2019","unstructured":"Helmke A, Nordlohne J, Balzer MS, Dong L, Rong S, Hiss M, Shushakova N, Haller H, von Vietinghoff S. CX3CL1-CX3CR1 interaction mediates macrophage-mesothelial cross talk and promotes peritoneal fibrosis. Kidney Int. 2019;95(6):1405\u201317.","journal-title":"Kidney Int"},{"issue":"4","key":"2002_CR31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3892\/mco.2025.2832","volume":"22","author":"C Miao","year":"2025","unstructured":"Miao C, Sun R, Ji D, Wu M, Fu Q, Mei L, Wu Z. Mechanism of the GALNT family proteins in regulating tumorigenesis and development of lung cancer (Review). Mol Clin Oncol. 2025;22(4):37.","journal-title":"Mol Clin Oncol"},{"issue":"4","key":"2002_CR32","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.immuni.2018.09.005","volume":"49","author":"B Daniel","year":"2018","unstructured":"Daniel B, Nagy G, Czimmerer Z, Horvath A, Hammers DW, Cuaranta-Monroy I, Poliska S, Tzerpos P, Kolostyak Z, Hays TT, Patsalos A, Houtman R, Sauer S, Francois-Deleuze J, Rastinejad F, Balint BL, Sweeney HL. Nagy. The nuclear receptor PPAR\u03b3 controls progressive macrophage polarization as a Ligand-Insensitive epigenomic ratchet of transcriptional memory. Immunity. 2018;49(4):615\u2013e626616.","journal-title":"Immunity"},{"issue":"1","key":"2002_CR33","doi-asserted-by":"crossref","first-page":"7269","DOI":"10.1038\/s41467-024-51736-5","volume":"15","author":"S Zuo","year":"2024","unstructured":"Zuo S, Wang Y, Bao H, Zhang Z, Yang N, Jia M, Zhang Q, Jian A, Ji R, Zhang L, Lu Y, Huang Y, Shen P. Lipid synthesis, triggered by PPAR\u03b3 T166 dephosphorylation, sustains reparative function of macrophages during tissue repair. Nat Commun. 2024;15(1):7269.","journal-title":"Nat Commun"},{"key":"2002_CR34","doi-asserted-by":"crossref","unstructured":"Cheng WY, Huynh H, Chen P, Pe\u00f1a-Llopis S. Y. Wan. Macrophage PPAR\u03b3 inhibits Gpr132 to mediate the anti-tumor effects of Rosiglitazone. Elife. 2016;5:e18501.","DOI":"10.7554\/eLife.18501"},{"issue":"11","key":"2002_CR35","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/ni.3011","volume":"15","author":"F Ginhoux","year":"2014","unstructured":"Ginhoux F, Fate. PPAR-titioning: PPAR-\u03b3 \u2018instructs\u2019 alveolar macrophage development. Nat Immunol. 2014;15(11):1005\u20137.","journal-title":"Nat Immunol"},{"issue":"1","key":"2002_CR36","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3892\/etm.2021.10146","volume":"22","author":"M Lin","year":"2021","unstructured":"Lin M, Deng K, Li Y, Wan J. Morphine enhances LPS-induced macrophage apoptosis through a PPAR\u03b3-dependent mechanism. Exp Ther Med. 2021;22(1):714.","journal-title":"Exp Ther Med"},{"key":"2002_CR37","doi-asserted-by":"crossref","unstructured":"Xinjing Wang L, Xiaoduan L, Feikai S, Huizhen L, Yingying W, Ziliang WX. The lnc-CTSLP8 upregulates CTSL1 as a competitive endogenous RNA and promotes ovarian cancer metastasis. J Exp Clin Cancer Res. 2021;40(1):151.","DOI":"10.1186\/s13046-021-01957-z"},{"key":"2002_CR38","doi-asserted-by":"crossref","unstructured":"Vassiliou E, Farias-Pereira R. Impact of lipid metabolism on macrophage polarization: implications for inflammation and tumor immunity. Int J Mol Sci. 2023;24(15):12032.","DOI":"10.3390\/ijms241512032"},{"key":"2002_CR39","doi-asserted-by":"crossref","unstructured":"Liu S, Zhang H, Li Y, Zhang Y, Bian Y, Zeng Y, Yao X, Wan J, Chen X, Li J, Wang Z, Qin Z. S100A4 enhances protumor macrophage polarization by control of PPAR-\u03b3-dependent induction of fatty acid oxidation. J Immunother Cancer. 2021;9(6):e002548.","DOI":"10.1136\/jitc-2021-002548"},{"issue":"3","key":"2002_CR40","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41590-023-01430-3","volume":"24","author":"PS Liu","year":"2023","unstructured":"Liu PS, Chen YT, Li X, Hsueh PC, Tzeng SF, Chen H, Shi PZ, Xie X, Parik S, Planque M, Fendt SM, Ho PC. CD40 signal rewires fatty acid and glutamine metabolism for stimulating macrophage anti-tumorigenic functions. Nat Immunol. 2023;24(3):452\u201362.","journal-title":"Nat Immunol"},{"issue":"4","key":"2002_CR41","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.immuni.2016.09.016","volume":"45","author":"SC Huang","year":"2016","unstructured":"Huang SC, Smith AM, Everts B, Colonna M, Pearce EL, Schilling JD, Pearce EJ. Metabolic reprogramming mediated by the mTORC2-IRF4 signaling axis is essential for macrophage alternative activation. Immunity. 2016;45(4):817\u201330.","journal-title":"Immunity"},{"issue":"1","key":"2002_CR42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cmet.2006.05.011","volume":"4","author":"D Vats","year":"2006","unstructured":"Vats D, Mukundan L, Odegaard JI, Zhang L, Smith KL, Morel CR, Wagner RA, Greaves DR, Murray PJ, Chawla A. Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. Cell Metab. 2006;4(1):13\u201324.","journal-title":"Cell Metab"},{"issue":"6","key":"2002_CR43","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cmet.2008.04.003","volume":"7","author":"JI Odegaard","year":"2008","unstructured":"Odegaard JI, Ricardo-Gonzalez RR, Red Eagle A, Vats D, Morel CR, Goforth MH, Subramanian V, Mukundan L, Ferrante AW, Chawla A. Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. Cell Metab. 2008;7(6):496\u2013507.","journal-title":"Cell Metab"},{"key":"2002_CR44","doi-asserted-by":"crossref","unstructured":"Mantovani A. Locati Massimo. Tumor-associated macrophages as a paradigm of macrophage plasticity, diversity, and polarization: lessons and open questions. Arterioscler Thromb Vasc Biol. 2013;33(7):1478\u201383.","DOI":"10.1161\/ATVBAHA.113.300168"},{"key":"2002_CR45","doi-asserted-by":"crossref","unstructured":"Mantovani A, Antonio S, Silvano S, Paola A, Annunciata V. Locati Massimo. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25(12):677\u201386.","DOI":"10.1016\/j.it.2004.09.015"},{"key":"2002_CR46","doi-asserted-by":"crossref","unstructured":"Sijin Cheng L, Ziyi G, Ranran X, Baocai G, Yunong Y, Yu Q, Shishang Z, Lei O, Hanqiang D, Peng J, Liang Z, Bin Y, Yue. Wang Xiliang, Ren Xianwen, Bei Jin-Xin, Hu Xueda, Bu Zhaode, Ji Jiafu, Zhang Zemin. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell. 2021;184(3):792-809.e23.","DOI":"10.1016\/j.cell.2021.01.010"},{"key":"2002_CR47","doi-asserted-by":"crossref","unstructured":"Ma R-Y, Annabel B. Qian Bin-Zhi. Macrophage diversity in cancer revisited in the era of single-cell omics. Trends Immunol. 2022;43(7):546\u201363.","DOI":"10.1016\/j.it.2022.04.008"},{"key":"2002_CR48","doi-asserted-by":"crossref","unstructured":"Jiawei Y, Tiffany H. Lipid metabolism in regulation of macrophage functions. Trends Cell Biol. 2020;30(12):979\u201389.","DOI":"10.1016\/j.tcb.2020.09.006"},{"key":"2002_CR49","doi-asserted-by":"crossref","unstructured":"Van den Jan ON, Luke A. Menon Deepthi. Macrophage Immunometabolism: where Are We (Going)? Trends Immunol. 2017;38(6):395\u2013406.","DOI":"10.1016\/j.it.2017.03.001"},{"key":"2002_CR50","doi-asserted-by":"crossref","unstructured":"Wei Wang L, Gary D. Metabolic therapy for the treatment of ischemic heart disease: reality and expectations. Expert Rev Cardiovasc Ther. 2007;5(6):1123\u201334.","DOI":"10.1586\/14779072.5.6.1123"},{"key":"2002_CR51","doi-asserted-by":"crossref","unstructured":"Isabel R, Schlaepfer J, Molishree. CPT1A-mediated fat Oxidation, Mechanisms, and therapeutic potential. Endocrinology. 2020;161(2):bqz046.","DOI":"10.1210\/endocr\/bqz046"},{"issue":"3","key":"2002_CR52","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/ni.3366","volume":"17","author":"J Nomura Mitsunori","year":"2016","unstructured":"Nomura Mitsunori J, Liu, Ilsa I, Rovira E, Gonzalez-Hurtado J, Lee MJ, Wolfgang. Toren Finkel. Fatty acid oxidation in macrophage polarization. Nat Immunol. 2016;17(3):216\u20137.","journal-title":"Nat Immunol"},{"key":"2002_CR53","doi-asserted-by":"crossref","unstructured":"Cynthia Hong T. Peter. Coordination of inflammation and metabolism by PPAR and LXR nuclear receptors. Curr Opin Genet Dev 2008, 18(5).","DOI":"10.1016\/j.gde.2008.07.016"},{"issue":"7148","key":"2002_CR54","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nature05894","volume":"447","author":"JI Odegaard","year":"2007","unstructured":"Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L, Red Eagle A, Vats D, Brombacher F, Ferrante AW, Chawla A. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature. 2007;447(7148):1116\u201320.","journal-title":"Nature"},{"key":"2002_CR55","doi-asserted-by":"crossref","unstructured":"Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998, 391(6662).","DOI":"10.1038\/34178"},{"key":"2002_CR56","doi-asserted-by":"crossref","unstructured":"Hongming Miao O, Juanjuan M, Yinyan G, Feng Y, Zhenggang W, Melvin L, Chaohong S, Wenxia H, Xianlin W, Miao. Cao Qiang, Chung Bik-Ho Florence, Yang Dan, Liang Houjie, Xue Bingzhong, Shi Hang, Gan Lixia, Yu Liqing. Macrophage CGI-58 deficiency activates ROS-inflammasome pathway to promote insulin resistance in mice. Cell Rep 2014, 7(1).","DOI":"10.1016\/j.celrep.2014.02.047"},{"issue":"5","key":"2002_CR57","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nm.3159","volume":"19","author":"M Ahmadian","year":"2013","unstructured":"Ahmadian M, Suh JM, Hah N, Liddle C, Atkins AR, Downes M. Evans. PPAR\u03b3 signaling and metabolism: the good, the bad and the future. Nat Med. 2013;19(5):557\u201366.","journal-title":"Nat Med"},{"issue":"7","key":"2002_CR58","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1210\/me.2005-0222","volume":"20","author":"I Iankova","year":"2006","unstructured":"Iankova I, Petersen RK, Annicotte JS, Chavey C, Hansen JB, Kratchmarova I, Sarruf D, Benkirane M, Kristiansen K, Fajas L. Peroxisome proliferator-activated receptor gamma recruits the positive transcription elongation factor b complex to activate transcription and promote adipogenesis. Mol Endocrinol (Baltimore Md). 2006;20(7):1494\u2013505.","journal-title":"Mol Endocrinol (Baltimore Md)"},{"issue":"4","key":"2002_CR59","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.bbrc.2011.12.086","volume":"417","author":"S Ji","year":"2012","unstructured":"Ji S, Park SY, Roth J, Kim HS, Cho JW. O-GlcNAc modification of PPAR\u03b3 reduces its transcriptional activity. Biochem Biophys Res Commun. 2012;417(4):1158\u201363.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"2002_CR60","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1007\/s10753-018-0789-4","volume":"41","author":"X Liu","year":"2018","unstructured":"Liu X, Li A, Ju Y, Liu W, Shi H, Hu R, Zhou Z, Sun X. \u03b24GalT1 mediates PPAR\u03b3 N-Glycosylation to attenuate microglia inflammatory activation. Inflammation. 2018;41(4):1424\u201336.","journal-title":"Inflammation"},{"key":"2002_CR61","doi-asserted-by":"crossref","unstructured":"John C, Chatham Z, Jianhua, Wende Adam R. Role of O-Linked N-Acetylglucosamine protein modification in cellular (Patho)Physiology. Physiol Rev. 2021;101(2):427\u201393.","DOI":"10.1152\/physrev.00043.2019"},{"key":"2002_CR62","doi-asserted-by":"crossref","unstructured":"Zhang H, Jialin M, Chunyan H, Xuehui L, Shiya Z, Yihan P, Changmin P, Ping L, Heng M, Yuqi X, Zhinuo J, Susree M, Anju D, Kupfer Gary M. Cai Mengjiao, Zhang Heng, Ma Junfeng, Li Juanjuan, Han Suxia, Pei Huadong. A ROS-mediated oxidation-O-GlcNAcylation cascade governs ferroptosis. Nat Cell Biol. 2025;27(8):1288\u2013300.","DOI":"10.1038\/s41556-025-01722-w"},{"key":"2002_CR63","doi-asserted-by":"crossref","unstructured":"Wei Tan J, Pei Z, Wanjun H, Zhaohua L, Shaofeng C, Lulu L, Yingge P, Changmin L, Zhuqing S, Aihua C, Yali Z, Wenge X, Yu. Yao Yi, Li Xiangpan, song Qibin, he Fuchu, Qin Weijie, Pei Huadong. Posttranscriptional regulation of de Novo lipogenesis by glucose-induced O-GlcNAcylation. Mol Cell. 2021;81(9):1890-1904.e7.","DOI":"10.1016\/j.molcel.2021.02.009"},{"issue":"1","key":"2002_CR64","first-page":"29","volume":"17","author":"HS Ahuja","year":"2003","unstructured":"Ahuja HS, Szanto A, Nagy L, Davies PJ. The retinoid X receptor and its ligands: versatile regulators of metabolic function, cell differentiation and cell death. J Biol Regul Homeost Agents. 2003;17(1):29\u201345.","journal-title":"J Biol Regul Homeost Agents"},{"issue":"7","key":"2002_CR65","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1365-2443.2012.01607.x","volume":"17","author":"T Umemoto","year":"2012","unstructured":"Umemoto T, Fujiki Y. Ligand-dependent nucleo-cytoplasmic shuttling of peroxisome proliferator-activated receptors, PPAR\u03b1 and PPAR\u03b3. Genes Cells: Devoted Mol Cell Mech. 2012;17(7):576\u201396.","journal-title":"Genes Cells: Devoted Mol Cell Mech"},{"key":"2002_CR66","doi-asserted-by":"crossref","unstructured":"Yanxiong Yu, Farooq Mohammad S, Eberhart M, Sabine J, Yidan K, Dominik Z, Tianzuo W, Christel S, Rony K, Wei Z, Xiang Y, Jun. Ebert Matthias P A, burgermeister Elke. Nuclear pore protein POM121 regulates subcellular localization and transcriptional activity of PPAR\u03b3. Cell Death Dis. 2024;15(1):7.","DOI":"10.1038\/s41419-023-06371-1"},{"key":"2002_CR67","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1242\/jcs.055475","volume":"123","author":"A von Knethen","year":"2010","unstructured":"von Knethen A, Tzieply N, Jennewein C, Br\u00fcne B. Casein-kinase-II-dependent phosphorylation of PPARgamma provokes CRM1-mediated shuttling of PPARgamma from the nucleus to the cytosol. J Cell Sci. 2010;123:192\u2013201.","journal-title":"J Cell Sci"},{"key":"2002_CR68","doi-asserted-by":"crossref","unstructured":"James V, Jester P, Eric, Brown Donald J. PPAR\u03b3 regulates mouse meibocyte differentiation and lipid synthesis. Ocul Surf. 2016;14(4):484\u201394.","DOI":"10.1016\/j.jtos.2016.08.001"},{"issue":"4","key":"2002_CR69","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/JLB.5MA1221-468R","volume":"112","author":"C Mao","year":"2022","unstructured":"Mao C, Zhuang SM, Xia Z, Xiao ZW, Huang CX, Su Q, Chen J, Liao J. Pan-cancer analysis of GALNTs expression identifies a prognostic of GALNTs feature in low grade glioma. J Leukoc Biol. 2022;112(4):887\u201399.","journal-title":"J Leukoc Biol"},{"issue":"5","key":"2002_CR70","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/s41419-020-2537-6","volume":"11","author":"J Song","year":"2020","unstructured":"Song J, Liu W, Wang J, Hao J, Wang Y, You X, Du X, Zhou Y, Ben J, Zhang X, Ye M, Wang Q. GALNT6 promotes invasion and metastasis of human lung adenocarcinoma cells through O-glycosylating chaperone protein GRP78. Cell Death Dis. 2020;11(5):352.","journal-title":"Cell Death Dis"},{"issue":"12","key":"2002_CR71","first-page":"2419","volume":"8","author":"J Duan","year":"2018","unstructured":"Duan J, Chen L, Gao H, Zhen T, Li H, Liang J, Zhang F, Shi H, Han A. GALNT6 suppresses progression of colorectal cancer. Am J Cancer Res. 2018;8(12):2419\u201335.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"2002_CR72","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s12672-025-02069-2","volume":"16","author":"TE Osman","year":"2025","unstructured":"Osman TE, Guo Y, Li S. Exploring the combined roles of GALNT1 and GALNT2 in hepatocellular carcinoma malignancy and EGFR modulation. Discov Oncol. 2025;16(1):337.","journal-title":"Discov Oncol"},{"issue":"5","key":"2002_CR73","doi-asserted-by":"crossref","first-page":"746","DOI":"10.4161\/onci.19535","volume":"1","author":"A Gaziel-Sovran","year":"2012","unstructured":"Gaziel-Sovran A, Hernando E. miRNA-mediated GALNT modulation of invasion and immune suppression: A sweet deal for metastatic cells. Oncoimmunology. 2012;1(5):746\u20138.","journal-title":"Oncoimmunology"},{"issue":"24","key":"2002_CR74","doi-asserted-by":"crossref","first-page":"8783","DOI":"10.1128\/MCB.01204-07","volume":"27","author":"M Tenno","year":"2007","unstructured":"Tenno M, Ohtsubo K, Hagen FK, Ditto D, Zarbock A, Schaerli P, von Andrian UH, Ley K, Le D, Tabak LA. Marth. Initiation of protein O glycosylation by the polypeptide GalNAcT-1 in vascular biology and humoral immunity. Mol Cell Biol. 2007;27(24):8783\u201396.","journal-title":"Mol Cell Biol"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-026-02002-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T05:17:28Z","timestamp":1770009448000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-026-02002-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":74,"alternative-id":["2002"],"URL":"https:\/\/doi.org\/10.1186\/s13048-026-02002-3","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"26 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocols were approved by the Ethics Committee of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Informed consent was obtained from all participants included in this study according to ethical committee regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree with the content of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}